N/A
Completed N=38
Defining Stress REsilience And Mindfulness Effects in Rheumatoid Arthritis
Arthritis, Rheumatoid
Source: ClinicalTrials.gov NCT06276387 ↗
Enrolled (actual)
38
Serious AEs
0.0%
Results posted
May 2026
Primary outcomePrimary: Patient Satisfaction as Assessed by CSQ-8, Adapted for DREAMER Study — 14; 0 Participants
Summary
This clinical trial will test a mindfulness program in individuals with rheumatoid arthritis (RA). The main goals of this pilot study are to:
* Assess patient satisfaction with a mindfulness course
* Identify barriers to participation in, or completion of, a mindfulness course
* Gather initial information to understand how a mindfulness course impacts RA symptoms
Participants will:
* Complete online questionnaires
* Attend two in-person study visits, involving a brief joint exam and blood draw
* Roughly half the participants will have the chance to participate in an 8-week online mindfulness course
* Roughly half the participants will be invited to participate in an online focus group following completion of the mindfulness course
Researchers will compare those in the mindfulness course with those receiving standard care in preparation for a larger future study to see how mindfulness impacts stress and inflammation in individuals with RA.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Patient Satisfaction as Assessed by CSQ-8, Adapted for DREAMER Study |
14; 0 | — |
| SECONDARY MBSR Course Attendance (Intervention Adherence) |
15; 0 | — |
| SECONDARY Percent of Study Completers (Study Retention) |
18; 19 | — |
Eligibility Criteria
Inclusion Criteria
- Physician-confirmed diagnosis of rheumatoid arthritis (RA)
- Access to a web-enabled computer, smartphone, or tablet
Exclusion Criteria
- RA disease activity in remission
- Current regular mindfulness practice (> 20 minutes per week)
- Inability to participate in an intensive 8-week online mindfulness course
- Prior participation in a mindfulness-based stress reduction (MBSR) course
Data sourced from ClinicalTrials.gov (NCT06276387). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.